[1]
Stapleton JT,
Foung S,
Muerhoff AS,
Bukh J,
Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 2011; 92(Pt 2): 233-46.
[2]
Naito H,
Abe K. Genotyping system of GBV-C/HGV type 1 to type 4 by the polymerase chain reaction using type-specific primers and geographical distribution of viral genotypes. J Virol Methods 2001; 91(1): 3-9.
[3] Fields BN, Knipe DM, Howley PM. Fields Virology. Vol 2, Chapter 32, Raven Press, 2007; p: 1022-4.
[4] Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Van Sant CL, Mushahwar IK. Identification of two flavivirus-like genomes in the GB hepatitis agent. Medical Proc Natl Acad SciUSA1995; 92(8): 3401–5.
[5]
Muerhoff AS,
Dawson GJ,
Desai SM. A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5'-untranslated region sequences. J Med Virol 2006; 78(1): 105-11.
[6]
Reshetnyak VI,
Karlovich TI,
Ilchenko LU. Hepatitis G virus. World J Gastroenterol 2008; 14(30): 4725-34.
[7] Stapleton JT, Williams CF, Xiang J. GB virus type C: a beneficial infection? J Clin Microbiol 2004; 42(9): 3915-9.
[8]
Ruiz V,
Giordano M,
Rivero CW,
Minassian ML,
Cuestas ML,
Trinks J,
Mathet VL,
Oubiña JR. GB virus C quasispecies detected in plasma and lymphocyte subsets in a natural human infection. J Gen Virol 2010; 91(Pt 7): 1687-92.
[9]
Mohr EL,
Stapleton JT. GB virus type C interactions with HIV: the role of envelope glycoproteins. J Viral Hepat 2009; 16(11): 757-68.
[10]
Wiwanitkit V. Hepatitis G virus RNA positivity among the voluntary blood donors: a summary.
Ann Hepatol 2005; 4(1): 43-6.
[11] Ziaee M, Zarban A, Malekinejad P, Akhbary H. Evaluation of HGV Viremia Prevalence and Its Co-Infection with HBV, HCV, HIV and HTLV-1 in Hemophilic Patients of Southern Khorassan, Iran. Hep Mon 2007; 7(1): 11-4.
[12] Ramezani A, Gachkar L, Eslamifar A, Hamkar R, Banifazl M, Yadegari D, Alilvand S, Adibi L, Salimi N, Naghili B, Khoushbaten M, Velayati A. A Prevalence of Hepatitis G virus Exposure in Blood Donors. Iranian J Infect Dis Trop Med 2007; 12(37): 41-6.
[13]
Berzsenyi MD,
Bowden DS,
Roberts SK. GB virus C: insights into co-infection.
J Clin Virol 2005; 33(4): 257-66.
[14]
Radkowski M,
Stańczak W,
Walewska-Zielecka B,
Loch T,
Cianciara J,
Wang LF,
Laskus T. Hepatitis G virus coinfection in chronic hepatitis B and C patients in Poland.
Infection 1998; 26(2): 113-5.
[15]
Polgreen PM,
Xiang J,
Chang Q,
Stapleton JT. GB virus type C/hepatitis G virus: a non-pathogenic flavivirus associated with prolonged survival in HIV-infected individuals.
Microbes Infect 2003; 5(13): 1255-61.
[16]
Williams CF,
Klinzman D,
Yamashita TE,
Xiang J,
Polgreen PM,
Rinaldo C,
Liu C,
Phair J,
Margolick JB,
Zdunek D,
Hess G,
Stapleton JT. Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 2004; 350(10): 981-90.
[17]
Tillmann HL,
Heringlake S,
Trautwein C,
Meissner D,
Nashan B,
Schlitt HJ,
Kratochvil J,
Hunt J,
Qiu X,
Lou SC,
Pichlmayr R,
Manns MP. Antibodies against the GB virus C envelope 2 protein before liver transplantation protect against GB virus C de novo infection. Hepatology 1998; 28(2): 379-84.
[18]
Lisco A,
Vanpouille C,
Margolis L. War and peace between microbes: HIV-1 interactions with coinfecting viruses.
Cell Host Microbe 2009; 6(5): 403-8.
[19]
Xiang J,
McLinden JH,
Chang Q,
Jordan EL,
Stapleton JT. Characterization of a peptide domain within the GB virus C NS5A phosphoprotein that inhibits HIV replication.
PLoS One 2008; 3(7): e2580.
[20]
Antonucci G,
Girardi E,
Cozzi-Lepri A,
Capobianchi MR,
Morsica G,
Pizzaferri P,
Ladisa N,
Sighinolfi L,
Chiodera A,
Solmone M,
Lalle E,
Ippolito G,
Monforte A;
HepaICoNA Study Group;
ICoNA Study Group. Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals.
Antivir Ther 2005; 10(1): 109-17.
[21]
Yang JF,
Dai CY,
Chuang WL,
Lin WY,
Lin ZY,
Chen SC,
Hsieh MY,
Wang LY,
Tsai JF,
Chang WY,
Yu ML. Prevalence and clinical significance of HGV/GBV-C infection in patients with chronic hepatitis B or C.
Jpn J Infect Dis 2006; 59(1): 25-30.
[22]
Bréchot C,
Jaffredo F,
Lagorce D,
Gerken G,
Meyer zum Büschenfelde K,
Papakonstontinou A,
Hadziyannis S,
Romeo R,
Colombo M,
Rodes J,
Bruix J,
Williams R,
Naoumov N. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
J Hepatol 1998; 29(2): 173-83.
[24]
Quarleri JF,
Mathet VL,
Feld M,
Ferrario D,
della Latta MP,
Verdun R,
Sánchez DO,
Oubiña JR. GB virus C/hepatitis G virus groups and subgroups: classification by a restriction fragment length polymorphism method based on phylogenetic analysis of the 5' untranslated region.
J Clin Microbiol 1999; 37(5): 1340-7.
[25]
Hekmat S,
Mohraz M,
Vahabpour R,
Jam S,
Bahramali G,
Banifazl M,
Aghakhani A,
Eslamifar A,
Mahboudi F,
Edalat R,
Ramezani A. Frequency and genotype of GB virus C among Iranian patients infected with HIV.
J Med Virol 2008; 80(11): 1941-6.
[26]
Stapleton JT. GB virus type C/Hepatitis G virus.
Semin Liver Dis 2003; 23(2): 137-48.
[27] Rezvan H, Sharafi M, Shams H, Mahmoodian Shooshtari M. A Preliminary Report on Prevalence of Antibody Response to GBV-C, E2 Protein in Iranian Blood Donors and Multitransfused Patients. Iranian J Publ Health 2007; 36(4): 6-11.
[28] Amini Kafi-Abad S , Samiei S, Talebian A, Maghsudloo M, Gharehbaghian A. Hepatitis G virus infection in Iranian Blood donors and High-Risk Groups. Hep Mon 2009; 9(4): 282-6.
[29]
Allen MI,
Gauthier J,
DesLauriers M,
Bourne EJ,
Carrick KM,
Baldanti F,
Ross LL,
Lutz MW,
Condreay LD. Two sensitive PCR-based methods for detection of hepatitis B virus variants associated with reduced susceptibility to lamivudine.
J Clin Microbiol 1999; 37(10): 3338-47.
[30]
Schleicher SB,
Flehmig BF. Genotyping of GB virus C by restriction pattern analysis of the 5' untranslated region.
J Med Virol 2003; 71(2): 226-32.
[31] Ghanbari R, Ravanshad M, Hosseini SY, Yaghobi R, Shahzamani K. Genotyping and Infection Rate of GBV-C Among Iranian HCV-Infected Patients. Hep Mon 2010; 10(2): 80-7.
[32]
Mukaide M,
Mizokami M,
Orito E,
Ohba K,
Nakano T,
Ueda R,
Hikiji K,
Iino S,
Shapiro S,
Lahat N,
Park YM,
Kim BS,
Oyunsuren T,
Rezieg M,
Al-Ahdal MN,
Lau JY. Three different GB virus C/hepatitis G virus genotypes. Phylogenetic analysis and a genotyping assay based on restriction fragment length polymorphism.
FEBS Lett 1997; 407(1): 51-8.
[33]
Künkel U,
Höhne M,
Berg T,
Hopf U,
Kekulé AS,
Frösner G,
Pauli G,
Schreier E. Quality control study on the performance of GB virus C/hepatitis G virus PCR.
J Hepatol 1998; 28(6): 978-84.
[34]
Lefrère JJ,
Férec C,
Roudot-Thoraval F,
Loiseau P,
Cantaloube JF,
Biagini P,
Mariotti M,
LeGac G,
Mercier B. GBV-C/hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals.
J Med Virol 1999; 59(1): 32-7.
[35] McPherson MJ, Moller SG. The Basic PCR. 2th Edition.USA: BIOS, 2006; p: 18-32.
Pathobiology Reserach